These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine. Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113 [TBL] [Abstract][Full Text] [Related]
3. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults. Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782 [TBL] [Abstract][Full Text] [Related]
4. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Suwansrinon K; Wilde H; Benjavongkulchai M; Banjongkasaena U; Lertjarutorn S; Boonchang S; Suttisri R; Khowplod P; Daviratanasilpa S; Sitprija V Vaccine; 2006 May; 24(18):3878-80. PubMed ID: 16530893 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of determination of rabies virus neutralizing antibody titres in the sera of vaccinated humans.]. Butirskiy AY; Muhacheva AV; Movsesyants AA; Sarkisyan KA Vopr Virusol; 2019; 64(6):298-305. PubMed ID: 32168444 [TBL] [Abstract][Full Text] [Related]
6. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149 [TBL] [Abstract][Full Text] [Related]
7. One or three intradermal injections within one week for rabies pre-exposure immunization. Khawplod P; Wilde H; Sriaroon C; Chomchey P; Kamolthum T; Sitprija V Dev Biol (Basel); 2008; 131():393-401. PubMed ID: 18634501 [TBL] [Abstract][Full Text] [Related]
8. The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. Lau C; Sisson J J Travel Med; 2002; 9(6):285-8. PubMed ID: 12962581 [TBL] [Abstract][Full Text] [Related]
9. Rabies Antibody Response After Booster Immunization: A Systematic Review and Meta-analysis. Langedijk AC; De Pijper CA; Spijker R; Holman R; Grobusch MP; Stijnis C Clin Infect Dis; 2018 Nov; 67(12):1932-1947. PubMed ID: 29788204 [TBL] [Abstract][Full Text] [Related]
11. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody. Lodmell DL; Parnell MJ; Weyhrich JT; Ewalt LC Vaccine; 2003 Sep; 21(25-26):3998-4002. PubMed ID: 12922136 [TBL] [Abstract][Full Text] [Related]
12. Rabies antibody response after two intradermal pre-exposure prophylaxis immunizations: An observational cohort study. De Pijper CA; Boersma J; Terryn S; Van Gucht S; Goorhuis A; Grobusch MP; Stijnis C Travel Med Infect Dis; 2018; 22():36-39. PubMed ID: 29631038 [TBL] [Abstract][Full Text] [Related]
13. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study. Cantaert T; Borand L; Kergoat L; Leng C; Ung S; In S; Peng Y; Phoeun C; Hing C; Taing CN; Saman M; Ong S; Mey C; Choeung R; Ly S; Dussart P; Bourhy H; Tarantola A Lancet Infect Dis; 2019 Dec; 19(12):1355-1362. PubMed ID: 31570311 [TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Alberer M; Gnad-Vogt U; Hong HS; Mehr KT; Backert L; Finak G; Gottardo R; Bica MA; Garofano A; Koch SD; Fotin-Mleczek M; Hoerr I; Clemens R; von Sonnenburg F Lancet; 2017 Sep; 390(10101):1511-1520. PubMed ID: 28754494 [TBL] [Abstract][Full Text] [Related]
15. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization. Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510 [TBL] [Abstract][Full Text] [Related]
16. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children. Vien NC; Feroldi E; Lang J Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):294-6. PubMed ID: 18191971 [TBL] [Abstract][Full Text] [Related]
17. Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults. Roukens AH; Vossen AC; van Dissel JT; Visser LG Vaccine; 2008 Jun; 26(27-28):3438-42. PubMed ID: 18511158 [TBL] [Abstract][Full Text] [Related]
18. Antibody response in Dutch marines to a single intramuscular rabies booster immunization 1-2.5 years after an intradermal pre-exposure schedule: An observational study. De Pijper CA; Terryn S; Van Gucht S; Grobusch MP; Goorhuis A; Stijnis C Travel Med Infect Dis; 2020; 38():101907. PubMed ID: 33157228 [No Abstract] [Full Text] [Related]
19. Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster. Furuya-Kanamori L; Ramsey L; Manson M; Gilbert B; Lau CL J Travel Med; 2020 Nov; 27(7):. PubMed ID: 31943042 [TBL] [Abstract][Full Text] [Related]